Daiichi Sankyo’s US subsidiary Luitpold Pharmaceuticals has been sent a warning letter by the FDA for “significant” and repeated quality …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

